Electronic nicotine delivery systems (ENDSs) are used by some smokers to reduce cigarette consumption. But, are they effective?

NIHI’s Director Professor Chris Bullen and international colleagues examined the extent to which ENDSs or a non-nicotine cigarette substitute influence tobacco-related toxicant exposure and cigarette consumption in smokers. They concluded, use of an ENDS with cigarette-like nicotine delivery can reduce exposure to a major pulmonary carcinogen, NNAL, even with concurrent smoking.

The study was funded by the National Institutes of Health, US Food and Drug Administration and published in The Lancet.

Read the full research article: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00022-9/fulltext